Filed: 2/14/2025ACC: 0001591986-25-000003
📋 What this filing means
AQUILO CAPITAL MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 14 equity positions with a total reported market value of $66.32M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
14
Positions
$66.32M
Total AUM (reported)
7.20M
Total Shares
Allocation by class
COM$55.98M84.4%
SPONSORED ADS$3.11M4.7%
SHS$2.66M4.0%
ADS$2.53M3.8%
COM NEW$2.04M3.1%
Portfolio Concentration
Top 3$33.40M50.4%
4–10$26.74M40.3%
11–25$6.17M9.3%
Top 3 weight
50.4%
Top 10 weight
90.7%
Voting Authority Distribution
Total shares with voting rights: 7.20M
Sole
Full voting authority
7.10M
shares
% of voting shares98.6%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
100K
shares
% of voting shares1.4%
Investment Discretion (by position count)
Sole14
Shared0
Other0
Dominant voting typeSole · 98.6% of voting shares
Institutional Holdings14
Rows:
ARROWHEAD PHARMACEUTICALS IN
SOLEShares782.59K
TypeSH
Market value$14.71M
22.19%
Sole
707.59K
Shared
0.00
None
75K
BLUEPRINT MEDICINES CORP
SOLEShares129.60K
TypeSH
Market value$11.30M
17.04%
Sole
129.60K
Shared
0.00
None
0.00
KYMERA THERAPEUTICS INC
SOLEShares183.52K
TypeSH
Market value$7.38M
11.13%
Sole
183.52K
Shared
0.00
None
0.00
AMGEN INC
SOLEShares25K
TypeSH
Market value$6.52M
9.83%
Sole
0.00
Shared
0.00
None
25K
ARVINAS INC
SOLEShares328.77K
TypeSH
Market value$6.30M
9.50%
Sole
328.77K
Shared
0.00
None
0.00
BICYCLE THERAPEUTICS PLC
SOLEShares221.91K
TypeSH
Market value$3.11M
4.68%
Sole
221.91K
Shared
0.00
None
0.00
PROTAGONIST THERAPEUTICS INC
SOLEShares76.59K
TypeSH
Market value$2.96M
4.46%
Sole
76.59K
Shared
0.00
None
0.00
REGENXBIO INC
SOLEShares346.30K
TypeSH
Market value$2.68M
4.04%
Sole
346.30K
Shared
0.00
None
0.00
IMMATICS N.V
SOLEShares373.90K
TypeSH
Market value$2.66M
4.01%
Sole
373.90K
Shared
0.00
None
0.00
SILENCE THERAPEUTICS PLC
SOLEShares367.21K
TypeSH
Market value$2.53M
3.81%
Sole
367.21K
Shared
0.00
None
0.00
ADICET BIO INC
SOLEShares2.53M
TypeSH
Market value$2.44M
3.67%
Sole
2.53M
Shared
0.00
None
0.00
PRECISION BIOSCIENCES INC
SOLEShares536.38K
TypeSH
Market value$2.04M
3.08%
Sole
536.38K
Shared
0.00
None
0.00
REPARE THERAPEUTICS INC
SOLEShares1.29M
TypeSH
Market value$1.69M
2.56%
Sole
1.29M
Shared
0.00
None
0.00
SUTRO BIOPHARMA INC
SOLEShares498.00
TypeSH
Market value$916.00
<0.01%
Sole
498.00
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ARROWHEAD PHARMACEUTICALS INSOLE | COM | 782.59K | SH | $14.71M 22.19% | 707.59K | 0.00 | 75K |
BLUEPRINT MEDICINES CORPSOLE | COM | 129.60K | SH | $11.30M 17.04% | 129.60K | 0.00 | 0.00 |
KYMERA THERAPEUTICS INCSOLE | COM | 183.52K | SH | $7.38M 11.13% | 183.52K | 0.00 | 0.00 |
AMGEN INCSOLE | COM | 25K | SH | $6.52M 9.83% | 0.00 | 0.00 | 25K |
ARVINAS INCSOLE | COM | 328.77K | SH | $6.30M 9.50% | 328.77K | 0.00 | 0.00 |
BICYCLE THERAPEUTICS PLCSOLE | SPONSORED ADS | 221.91K | SH | $3.11M 4.68% | 221.91K | 0.00 | 0.00 |
PROTAGONIST THERAPEUTICS INCSOLE | COM | 76.59K | SH | $2.96M 4.46% | 76.59K | 0.00 | 0.00 |
REGENXBIO INCSOLE | COM | 346.30K | SH | $2.68M 4.04% | 346.30K | 0.00 | 0.00 |
IMMATICS N.VSOLE | SHS | 373.90K | SH | $2.66M 4.01% | 373.90K | 0.00 | 0.00 |
SILENCE THERAPEUTICS PLCSOLE | ADS | 367.21K | SH | $2.53M 3.81% | 367.21K | 0.00 | 0.00 |
ADICET BIO INCSOLE | COM | 2.53M | SH | $2.44M 3.67% | 2.53M | 0.00 | 0.00 |
PRECISION BIOSCIENCES INCSOLE | COM NEW | 536.38K | SH | $2.04M 3.08% | 536.38K | 0.00 | 0.00 |
REPARE THERAPEUTICS INCSOLE | COM | 1.29M | SH | $1.69M 2.56% | 1.29M | 0.00 | 0.00 |
SUTRO BIOPHARMA INCSOLE | COM | 498.00 | SH | $916.00 <0.01% | 498.00 | 0.00 | 0.00 |